Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AEHAW
Aesther Healthcare Acquisition
$0.03
+17.8%
$0.03
$0.06
$0.33
N/AN/A34,287 shs103,348 shs
Anzu Special Acquisition Corp I stock logo
ANZUW
Anzu Special Acquisition Corp I
$0.04
$0.04
$0.00
$0.15
N/AN/A32,101 shsN/A
LBPSW
4D pharma
$0.00
$0.04
$1.29
N/AN/A20,931 shsN/A
ToughBuilt Industries, Inc. WT EXP 110923 stock logo
TBLTW
ToughBuilt Industries, Inc. WT EXP 110923
$0.01
$0.01
$0.00
$0.33
N/AN/A18,151 shs37,347 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AEHAW
Aesther Healthcare Acquisition
+9.05%-13.06%+19.91%-12.76%-74.18%
Anzu Special Acquisition Corp I stock logo
ANZUW
Anzu Special Acquisition Corp I
0.00%0.00%+40.35%-25.51%-76.46%
LBPSW
4D pharma
0.00%0.00%0.00%0.00%0.00%
ToughBuilt Industries, Inc. WT EXP 110923 stock logo
TBLTW
ToughBuilt Industries, Inc. WT EXP 110923
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AEHAW
Aesther Healthcare Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Anzu Special Acquisition Corp I stock logo
ANZUW
Anzu Special Acquisition Corp I
N/AN/AN/AN/AN/AN/AN/AN/A
LBPSW
4D pharma
N/AN/AN/AN/AN/AN/AN/AN/A
ToughBuilt Industries, Inc. WT EXP 110923 stock logo
TBLTW
ToughBuilt Industries, Inc. WT EXP 110923
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AEHAW
Aesther Healthcare Acquisition
0.00
N/AN/AN/A
Anzu Special Acquisition Corp I stock logo
ANZUW
Anzu Special Acquisition Corp I
0.00
N/AN/AN/A
LBPSW
4D pharma
0.00
N/AN/AN/A
ToughBuilt Industries, Inc. WT EXP 110923 stock logo
TBLTW
ToughBuilt Industries, Inc. WT EXP 110923
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AEHAW
Aesther Healthcare Acquisition
N/AN/AN/AN/AN/AN/A
Anzu Special Acquisition Corp I stock logo
ANZUW
Anzu Special Acquisition Corp I
N/AN/AN/AN/AN/AN/A
LBPSW
4D pharma
$522KN/AN/AN/AN/AN/A
ToughBuilt Industries, Inc. WT EXP 110923 stock logo
TBLTW
ToughBuilt Industries, Inc. WT EXP 110923
$99.24MN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AEHAW
Aesther Healthcare Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Anzu Special Acquisition Corp I stock logo
ANZUW
Anzu Special Acquisition Corp I
N/AN/A0.00N/AN/AN/AN/AN/A
LBPSW
4D pharma
N/AN/A0.00N/AN/AN/AN/AN/AN/A
ToughBuilt Industries, Inc. WT EXP 110923 stock logo
TBLTW
ToughBuilt Industries, Inc. WT EXP 110923
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AEHAW
Aesther Healthcare Acquisition
N/AN/AN/AN/AN/A
Anzu Special Acquisition Corp I stock logo
ANZUW
Anzu Special Acquisition Corp I
N/AN/AN/AN/AN/A
LBPSW
4D pharma
N/AN/AN/AN/AN/A
ToughBuilt Industries, Inc. WT EXP 110923 stock logo
TBLTW
ToughBuilt Industries, Inc. WT EXP 110923
N/AN/AN/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AEHAW
Aesther Healthcare Acquisition
2N/AN/ANot Optionable
Anzu Special Acquisition Corp I stock logo
ANZUW
Anzu Special Acquisition Corp I
2N/AN/ANot Optionable
LBPSW
4D pharma
N/AN/AN/ANot Optionable
ToughBuilt Industries, Inc. WT EXP 110923 stock logo
TBLTW
ToughBuilt Industries, Inc. WT EXP 110923
N/AN/AN/ANot Optionable

Recent News About These Companies

EVLVW Evolv Technologies Holdings, Inc. WT EXP 031025
ToughBuilt Industries, Inc. WT EXP 110923 (TBLTW)
USGOW U.S. GoldMining Inc. WT EXP
NNAVW NextNav Inc. WT EXP 102826
STSSW Sharps Technology, Inc. WT EXP 041327
ECXWW ECARX Holdings Inc. WT EXP 122027
ZFOXW ZeroFox Holdings, Inc. WT EXP 080327
GGROW Gogoro Inc. WT EXP 040427

Aesther Healthcare Acquisition NASDAQ:AEHAW

$0.03 +0.00 (+17.79%)
As of 04/23/2025

Aesther Healthcare Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.

Anzu Special Acquisition Corp I stock logo

Anzu Special Acquisition Corp I NASDAQ:ANZUW

$0.04 0.00 (0.00%)
As of 04/21/2025

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

4D pharma NASDAQ:LBPSW

4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company develops therapeutic candidates, such as MRx0518; MRx-4DP000 for the treatment of asthma and COVID-19; MRx0029 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn's disease. It also develops products candidates, including MRx1299 for solid tumors, MRx0005 for neurodegeneration, MRx0006 for rheumatoid arthritis, and MRx0002 for multiple sclerosis. The company develops MicroRx platform to discover new LBP candidates for major diseases. 4D pharma plc has a collaboration agreement with Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda and MRx0518 in patients with solid tumors. The company was formerly known as Schosween 18 Limited. 4D pharma plc was incorporated in 2014 and is headquartered in Leeds, the United Kingdom.

ToughBuilt Industries, Inc. WT EXP 110923 stock logo

ToughBuilt Industries, Inc. WT EXP 110923 NASDAQ:TBLTW

ToughBuilt Industries Inc. is an advanced product design, manufacturer and distributor with emphasis on innovative products. Currently focused on tools and other accessories for the professional and do-it-yourself construction industries. The Company markets and distributes various home improvement and construction product lines for both the do-it-yourself and professional markets under the TOUGHBUILT brand name, within the global multibillion dollar per year tool market industry. All of its products are designed by its in-house design team. Since launching product sales in 2013, the company has experienced significant annual sales growth. Its current product line includes three major categories, with several additional categories in various stages of development, consisting of Soft Goods & Kneepads and Sawhorses & Work Products. Its mission is to provide products to the building and home improvement communities that are innovative, of superior quality derived in part from enlightened creativity for its end users while enhancing performance, improving well-being and building high brand loyalty.